Navamedic ASA (NAVA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Navamedic ASA (NAVA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7496
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. The company offers its products to patients, hospitals and pharmacies in the Nordic, Benelux and Baltic markets. Navamedic offers its pharmaceutical products under mouth and throat health, dermatology, urology, gynecology, cardiology and other categories; and medical devices under urine measurement and psychiatry categories. The company also distributes products supplied by several pharmaceutical manufacturers. Navamedic is headquartered in Lysaker, Norway.

Navamedic ASA (NAVA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Navamedic ASA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Navamedic ASA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Navamedic ASA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Navamedic ASA, Medical Equipment, Deal Details 10
Venture Financing 10
Observe Medical To Raise US$1.7 Million In Venture Financing 10
Partnerships 11
Navamedic Enters into Agreement with Chemviron Carbon 11
Navamedic Enters into Distribution Agreement with Re5 12
Observe Medical Enters into Development Agreement with GE Healthcare Systems Sverige 13
Pfm Medical Enters into Distribution Agreement with Observe Medical 14
Equity Offering 15
Navamedic Raises USD1.3 Million in Private Placement of Shares 15
Acquisition 16
Navamedic Acquires Observe Medical 16
Navamedic ASA – Key Competitors 17
Navamedic ASA – Key Employees 18
Navamedic ASA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Aug 24, 2018: Navamedic: Q2 2018 results 20
May 30, 2018: Navamedic Announces Q1 2018 results 21
Feb 15, 2018: Navamedic: Q4 2017 Results 22
Nov 10, 2017: Navamedic: Q3 2017 results 23
Jul 28, 2017: Navamedic ASA: Second quarter results 2017 24
Jul 28, 2017: Navamedic: Second quarter results 2017 25
May 10, 2017: Navamedic: Q1 2017 Results 26
Feb 15, 2017: Navamedic: Q4 2016 results 27
Corporate Communications 28
Oct 01, 2018: Navamedic announce Tom Ronnlund to step down as CEO 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Navamedic ASA, Medical Equipment, Key Facts, 2017 2
Navamedic ASA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Navamedic ASA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Navamedic ASA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Deals By Market, 2012 to YTD 2018 8
Navamedic ASA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Observe Medical To Raise US$1.7 Million In Venture Financing 10
Navamedic Enters into Agreement with Chemviron Carbon 11
Navamedic Enters into Distribution Agreement with Re5 12
Observe Medical Enters into Development Agreement with GE Healthcare Systems Sverige 13
Pfm Medical Enters into Distribution Agreement with Observe Medical 14
Navamedic Raises USD1.3 Million in Private Placement of Shares 15
Navamedic Acquires Observe Medical 16
Navamedic ASA, Key Competitors 17
Navamedic ASA, Key Employees 18
Navamedic ASA, Subsidiaries 19

List of Figures
Navamedic ASA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Navamedic ASA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Navamedic ASA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Navamedic ASA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Navamedic ASA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Navamedic ASA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Navamedic ASA (NAVA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Renova Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Renova Therapeutics Inc (Renova) is a drug development company that focuses on the development of peptide infusion therapies and gene therapy treatments for cardiovascular and metabolic diseases. The company’s pipeline products include RT-100, RT-200, RT-110, RT-400, RT-210 and RT-300. Its R …
  • Enerflex Ltd (EFX):企業の財務・戦略的SWOT分析
    Enerflex Ltd (EFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Brazos Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Brazos Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • American Bio Medica Corp (ABMC):企業の製品パイプライン分析2018
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing product that detects 1-10 drugs of abuse in a urine specimen; Rapid One, a test cassette which is …
  • Kkr Financial Holdings Llc:企業の戦略・SWOT・財務分析
    Kkr Financial Holdings Llc - Strategy, SWOT and Corporate Finance Report Summary Kkr Financial Holdings Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cantargia AB (CANTA):企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of cancers including non-small cell lung cancer and pancreatic cancer. It utilize …
  • Nordic Investment Bank:電力:M&Aディール及び事業提携情報
    Summary Nordic Investment Bank (NIB) is a banking and financial service provider that offers loans and capital market solutions. The company offers loan products such as project and structured loans, corporate loans, municipality’s loans, environmental loans, sovereign loans, and other loans. It als …
  • Saga plc:企業の戦略・SWOT・財務情報
    Saga plc - Strategy, SWOT and Corporate Finance Report Summary Saga plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • J.E. Dunn Construction Group Inc:企業の戦略的SWOT分析
    J.E. Dunn Construction Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Smithfield Foods Inc:企業のM&A・事業提携・投資動向
    Smithfield Foods Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smithfield Foods Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • PromptCare Inc-製薬・医療分野:企業M&A・提携分析
    Summary PromptCare Inc (PromptCare) is a healthcare center that respiratory products and home infusion services. The center provides respiratory services such as clinical support programs, patient-focused technology and testimonials. It provides home infusion therapies for patients of all ages with …
  • Clean Energy Finance Corp:電力:M&Aディール及び事業提携情報
    Summary Clean Energy Finance Corp (CEFC) is a statutory authority that provides investments for clean energy projects including renewable energy, energy efficiency and low emissions technologies. The authority financing structures include project finance, climate bonds and equity funds, aggregation …
  • Westrock Company:企業の戦略・SWOT・財務情報
    Westrock Company - Strategy, SWOT and Corporate Finance Report Summary Westrock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cogentix Medical Inc (CGNT):企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • China CITIC Bank Corporation Limited:企業の戦略・SWOT・財務情報
    China CITIC Bank Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China CITIC Bank Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Probiogen AG-製薬・医療分野:企業M&A・提携分析
    Summary Probiogen AG (Probiogen), a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeu …
  • Takuma Co Ltd (6013):企業の財務・戦略的SWOT分析
    Takuma Co Ltd (6013) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Wuxi Pharmatech (Cayman) Inc:企業のM&A・事業提携・投資動向
    Wuxi Pharmatech (Cayman) Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wuxi Pharmatech (Cayman) Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • DuluxGroup Ltd:企業の戦略・SWOT・財務情報
    DuluxGroup Ltd - Strategy, SWOT and Corporate Finance Report Summary DuluxGroup Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆